Purchases and Sales Made in Q2 2024 in Mereo Biopharma Group PLC (MREO)
This table provides information about the institutional ownership of Mereo Biopharma Group PLC (MREO) during Q2 2024. The information is specifically focused on institutions that hold shares of Mereo Biopharma Group plc.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 07, 2024
Q2 2024
|
Monaco Asset Management Sam
|
SELL
|
- |
-56.9K- 14.04% |
$147K - $242K
|
348K
$1.05M
|
|
Aug 14, 2024
Q2 2024
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-76K- 69.55% |
$196K - $323K
|
33.3K
$100K
|
|
Aug 14, 2024
Q2 2024
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
SELL
|
- |
-104K- 87.71% |
$269K - $444K
|
14.6K
$44K
|
|
Aug 14, 2024
Q2 2024
|
Fred Alger Management, LLC
New York, NY |
SELL
|
- |
-146K- 74.7% |
$376K - $619K
|
49.3K
$148K
|
|
Aug 14, 2024
Q2 2024
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-150K- 42.63% |
$387K - $637K
|
202K
$607K
|
|
Aug 14, 2024
Q2 2024
|
Verition Fund Management LLC
Greenwich, CT |
SELL
|
- |
-259K- 53.34% |
$668K - $1.1M
|
226K
$682K
|
|
Aug 09, 2024
Q2 2024
|
Abrdn PLC
|
SELL
|
- |
-744K- 91.05% |
$1.92M - $3.16M
|
73.2K
$220K
|
|
Aug 14, 2024
Q2 2024
|
683 Capital Management, LLC
New York, NY |
SELL
|
- |
-750K- 13.04% |
$1.94M - $3.19M
|
5M
$15M
|
|
Aug 15, 2024
Q2 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-779K- 48.12% |
$2.01M - $3.31M
|
840K
$2.53M
|
|
Aug 14, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-1.17M- 84.98% |
$3.03M - $4.99M
|
208K
$625K
|
|
Oct 17, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-1.17M- 84.98% |
$3.03M - $4.99M
|
208K
$625K
|
|
Aug 14, 2024
Q2 2024
|
Soleus Capital Management, L.P.
Greenwich, CT |
SELL
|
- |
-1.37M- 52.35% |
$3.53M - $5.82M
|
1.25M
$3.75M
|
|
Aug 14, 2024
Q2 2024
|
Suvretta Capital Management, LLC
New York, NY |
SELL
|
- |
-3.58M- 97.95% |
$9.23M - $15.2M
|
75K
$226K
|